IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Stonepine Capital Management, LLC

Q4 2023 Holdings

Filed 2024-02-13 | 16 holdings | $231.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Evolus Inc(EOLS)COM30052C107$56.2M5,333,00424.3%
Adma Biologics Inc(ADMA)COM000899104$41.7M9,222,61718.0%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$36.8M2,500,00015.9%
Quidelortho Corp(QDEL)COM219798105$33.2M450,00014.3%
Alimera Sciences IncCOM NEW016259202$17.3M3,999,4597.5%
Xeris Biopharma Holdings Inc(XERS)COM98422E103$14.0M5,937,0006.0%
Galapagos NV(GLPG)SPONS ADR36315X101$10.6M261,8704.6%
Xoma Corp(XOMA)COM NEW98419J206$4.6M250,0002.0%
IO Biotech Inc(IOBT)COM449778109$3.1M1,666,0371.4%
Scynexis Inc(SCYX)COM NEW811292200$3.0M1,355,1861.3%
Rezolute Inc(RZLT)COM NEW76200L309$2.7M2,768,6561.2%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$2.6M839,5141.1%
Tela BIO Inc(TELA)COM872381108$2.1M317,7820.9%
Aytu Biopharma Inc(AYTU)COM054754858$1.3M472,4690.6%
Exagen Inc(XGN)COM30068X103$1.3M669,6840.6%
Atyr Pharma Inc(ATYR)COM NEW002120202$680.0K482,2580.3%